Two commercial assays were evaluated using an Ion AmpliSeq TB panel consisting of 8 whole-gene targets for 10 drugs (11) and the Deeplex Myc-TB assay targeting 6 whole-gene and hot spot regions of 12 genes for 14 drugs (15). The gene discussed is MYC; the disease is tuberculosis.